Jamila Dhiab
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Publisher Correction: Collagen VI is a fibrosis-associated signal disrupting muscle regeneration across distinct human myopathies.
Journal: EMBO reports
Published: July 01, 2026
Different outcomes of endurance and resistance exercise in skeletal muscles of Oculopharyngeal muscular dystrophy.
Journal: Journal of cachexia, sarcopenia and muscle
Published: January 25, 2024
IL-7 producing immunotherapy improves ex vivo T cell functions of immunosenescent patients, especially post hip fracture.
Journal: Human vaccines & immunotherapeutics
Published: July 07, 2023
Expression of immune checkpoint on subset of monocytes in old patients.
Journal: Experimental gerontology
Published: June 09, 2023
Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
Journal: Acta neuropathologica
Published: June 15, 2022
A negative feedback loop between fibroadipogenic progenitors and muscle fibres involving endothelin promotes human muscle fibrosis.
Journal: Journal of cachexia, sarcopenia and muscle
Published: July 28, 2021
Anti-prion Drugs Targeting the Protein Folding Activity of the Ribosome Reduce PABPN1 Aggregation.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics
Published: December 13, 2020
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy.
Journal: Human molecular genetics
Published: November 05, 2018
Last Updated: 09/26/2026